Free Trial

Barrington Research's Rating of Lifecore Biomedical on 4/29/2026

On April 29, 2026, Barrington Research updated its outlook on Lifecore Biomedical (NASDAQ:LFCR) with the action "Boost Price Target", setting a price target of $6.00. MarketBeat All Access subscribers can view the full ratings details, 12-month ROI, historical price target changes, and related news coverage on this page.

unlock icon  Upgrade to MarketBeat All Access

This premium research tool is available to MarketBeat All Access subscribers only. Log in to your account or sign up below.

Already have an account? Log in here.